Citigroup’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $435M | Buy |
15,493,259
+1,228,140
| +9% | +$32.7M | 0.19% | 98 |
|
|
2025
Q4 | $355M | Buy |
14,265,119
+7,051,151
| +98% | +$178M | 0.16% | 112 |
|
|
2025
Q3 | $184M | Sell |
7,213,968
-2,944,274
| -29% | -$72.7M | 0.08% | 238 |
|
|
2025
Q2 | $246M | Sell |
10,158,242
-189,445
| -2% | -$4.42M | 0.12% | 169 |
|
|
2025
Q1 | $262M | Buy |
10,347,687
+5,098,730
| +97% | +$133M | 0.13% | 139 |
|
|
2024
Q4 | $139M | Buy |
5,248,957
+1,285,984
| +32% | +$34.9M | 0.08% | 215 |
|
|
2024
Q3 | $115M | Sell |
3,962,973
-1,482,225
| -27% | -$43.2M | 0.07% | 252 |
|
|
2024
Q2 | $152M | Sell |
5,445,198
-914,442
| -14% | -$25.2M | 0.1% | 186 |
|
|
2024
Q1 | $176M | Buy |
6,359,640
+51,090
| +0.8% | +$1.42M | 0.12% | 160 |
|
|
2023
Q4 | $182M | Buy |
6,308,550
+1,580,936
| +33% | +$47.8M | 0.13% | 140 |
|
|
2023
Q3 | $157M | Sell |
4,727,614
-115,946
| -2% | -$4.1M | 0.12% | 144 |
|
|
2023
Q2 | $178M | Buy |
4,843,560
+445,528
| +10% | +$17.3M | 0.12% | 128 |
|
|
2023
Q1 | $179M | Sell |
4,398,032
-759,913
| -15% | -$32.8M | 0.13% | 125 |
|
|
2022
Q4 | $264M | Buy |
5,157,945
+285,485
| +6% | +$13.7M | 0.21% | 86 |
|
|
2022
Q3 | $213M | Buy |
4,872,460
+453,462
| +10% | +$22M | 0.15% | 105 |
|
|
2022
Q2 | $232M | Sell |
4,418,998
-864,610
| -16% | -$44.1M | 0.17% | 101 |
|
|
2022
Q1 | $274M | Buy |
5,283,608
+1,303,492
| +33% | +$67.6M | 0.17% | 98 |
|
|
2021
Q4 | $235M | Sell |
3,980,116
-570,588
| -13% | -$28.3M | 0.13% | 141 |
|
|
2021
Q3 | $196M | Sell |
4,550,704
-2,246,203
| -33% | -$99.5M | 0.12% | 146 |
|
|
2021
Q2 | $266M | Sell |
6,796,907
-621,228
| -8% | -$24.2M | 0.16% | 117 |
|
|
2021
Q1 | $269M | Sell |
7,418,135
-1,012,114
| -12% | -$35.9M | 0.17% | 107 |
|
|
2020
Q4 | $310M | Sell |
8,430,249
-1,074,105
| -11% | -$39.4M | 0.18% | 95 |
|
|
2020
Q3 | $331M | Buy |
9,504,354
+1,895,420
| +25% | +$66.5M | 0.22% | 72 |
|
|
2020
Q2 | $236M | Buy |
7,608,934
+535,280
| +8% | +$18.2M | 0.18% | 90 |
|
|
2020
Q1 | $219M | Sell |
7,073,654
-446,543
| -6% | -$15.2M | 0.2% | 77 |
|
|
2019
Q4 | $280M | Buy |
7,520,197
+1,359,248
| +22% | +$48.4M | 0.2% | 87 |
|
|
2019
Q3 | $210M | Sell |
6,160,949
-17,872
| -0.3% | -$650K | 0.17% | 105 |
|
|
2019
Q2 | $254M | Buy |
6,178,821
+1,107,358
| +22% | +$44M | 0.21% | 81 |
|
|
2019
Q1 | $204M | Sell |
5,071,463
-349,770
| -6% | -$14M | 0.2% | 85 |
|
|
2018
Q4 | $225M | Buy |
5,421,233
+35,333
| +0.7% | +$1.47M | 0.23% | 73 |
|
|
2018
Q3 | $225M | Sell |
5,385,900
-413,011
| -7% | -$15.9M | 0.2% | 83 |
|
|
2018
Q2 | $200M | Buy |
5,798,911
+2,042,420
| +54% | +$69.8M | 0.18% | 87 |
|
|
2018
Q1 | $126M | Sell |
3,756,491
-2,401,347
| -39% | -$82.6M | 0.1% | 153 |
|
|
2017
Q4 | $212M | Buy |
6,157,838
+50,956
| +0.8% | +$1.74M | 0.17% | 93 |
|
|
2017
Q3 | $207M | Buy |
6,106,882
+1,637,485
| +37% | +$52.6M | 0.17% | 81 |
|
|
2017
Q2 | $142M | Sell |
4,469,397
-445,955
| -9% | -$14.1M | 0.13% | 104 |
|
|
2017
Q1 | $160M | Sell |
4,915,352
-942,861
| -16% | -$29.7M | 0.14% | 88 |
|
|
2016
Q4 | $181M | Sell |
5,858,213
-595,957
| -9% | -$18.2M | 0.16% | 90 |
|
|
2016
Q3 | $207M | Buy |
6,454,170
+1,613,368
| +33% | +$53.9M | 0.19% | 72 |
|
|
2016
Q2 | $162M | Buy |
4,840,802
+1,372,826
| +40% | +$43.8M | 0.17% | 88 |
|
|
2016
Q1 | $97.5M | Sell |
3,467,976
-5,513,214
| -61% | -$157M | 0.11% | 156 |
|
|
2015
Q4 | $275M | Buy |
8,981,190
+5,087,336
| +131% | +$160M | 0.27% | 45 |
|
|
2015
Q3 | $116M | Sell |
3,893,854
-6,260,346
| -62% | -$201M | 0.11% | 141 |
|
|
2015
Q2 | $323M | Buy |
10,154,200
+2,096,658
| +26% | +$68.3M | 0.29% | 34 |
|
|
2015
Q1 | $266M | Buy |
8,057,542
+2,323,526
| +41% | +$73.9M | 0.26% | 47 |
|
|
2014
Q4 | $169M | Sell |
5,734,016
-1,796,842
| -24% | -$51.5M | 0.15% | 106 |
|
|
2014
Q3 | $211M | Sell |
7,530,858
-3,482,059
| -32% | -$97.7M | 0.18% | 73 |
|
|
2014
Q2 | $310M | Buy |
11,012,917
+4,268,916
| +63% | +$122M | 0.3% | 40 |
|
|
2014
Q1 | $206M | Sell |
6,744,001
-2,013,374
| -23% | -$60M | 0.21% | 68 |
|
|
2013
Q4 | $254M | Buy |
8,757,375
+396,225
| +5% | +$11.5M | 0.23% | 59 |
|
|
2013
Q3 | $228M | Sell |
8,361,150
-2,273,191
| -21% | -$61.9M | 0.21% | 57 |
|
|
2013
Q2 | $283M | Buy |
+10,634,341
| New | +$294M | 0.28% | 39 |
|
Other funds holding PFE
VCM
VPM
Citigroup's PFE Position: Q1 2026 in Review
Citigroup increased its Pfizer (PFE) stake by 8.6% in Q1 2026, buying an estimated $32.7M and bringing the position to 15,493,259 shares worth $435M. The position accounts for 0.19% of the portfolio, ranked #98.
Citigroup first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Citigroup held 15,493,259 shares of Pfizer worth $435M as of Q1 2026.
- Citigroup bought 1,228,140 Pfizer shares in Q1 2026, an estimated $32.7M.
- Pfizer made up 0.19% of Citigroup's portfolio in Q1 2026, its #98 holding.
- Citigroup first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.